ISTH 2022
ISTH 2022 July 9-13, London Read more
This author has yet to write their bio.Meanwhile lets just say that we are proud aplagoncom contributed a whooping 6 entries.
ISTH 2022 July 9-13, London Read more
LSX World 2022 May 10-11, London (in-person) May 16-20 (online) Read more
HELSINKI, September 1, 2021. Aplagon Oy (“Aplagon”), the Finnish pharmaceutical development company developing first-in-class vasculoprotective antithrombotic compounds to treat vascular injury related blood vessel occlusions and tissue damage, today announced the publication of new data as well as an accompanying commentary by third-party experts in the leading, peer-reviewed Journal of Cardiovascular Pharmacology. The article, “Safety […]
HELSINKI, May 28, 2021. Aplagon Oy (“Aplagon”), the Finnish pharmaceutical development company developing first-in-class vasculoprotective antithrombotic compounds to treat vascular injury related blood vessel occlusions and tissue damage, today announced the closing of a EUR 2.2 million funding round. The fundraise was arranged in collaboration with Invesdor Group and was oversubscribed. These funds increase the […]
HELSINKI, November 13, 2018. Aplagon Oy (“Aplagon”), today announced that patent, “Therapeutic APAC Molecule Comprising Heparin Conjugated to a Plasma Protein” has been granted by the European Patent Office (patent number EP 3185907 (A1)) and the Companies and Intellectual Property Commission of South Africa (patent number 2017/00701). The claims of the patent cover the composition […]
HELSINKI AND STOCKHOLM, September 19, 2017. Aplagon Oy (“Aplagon”) and Cadila Pharmaceuticals Sweden AB today announced a development and commercialization agreement for Aplagon’s lead APAC product. APACs are proprietary, locally acting, potent antithrombotic products, which target blood vessel wall injury. Under the agreement, Cadila Pharmaceuticals Sweden AB together with its parent company Cadila Pharmaceuticals Limited, […]
Website by Instinctif Partners
Aplagon Oy
Biomedicum Helsinki 2A
Tukholmankatu 8 A, 00290 Helsinki, Finland